152 related articles for article (PubMed ID: 32199670)
21. The natural history of PBC: has it changed?
Lee YM; Kaplan MM
Semin Liver Dis; 2005 Aug; 25(3):321-6. PubMed ID: 16143947
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
23. The therapeutic effect of UDCA is a factor in determining the prognosis of primary biliary cirrhosis.
Zeniya M; Wada T
J Gastroenterol; 2014 Oct; 49(10):1438-9. PubMed ID: 24898105
[No Abstract] [Full Text] [Related]
24. [Management of PBC cases failing to respond to UDCA].
Tanaka A
Nihon Shokakibyo Gakkai Zasshi; 2013 Jan; 110(1):16-21. PubMed ID: 23303227
[No Abstract] [Full Text] [Related]
25. Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future.
Poupon RE
J Hepatol; 2000 Apr; 32(4):685-8. PubMed ID: 10782919
[No Abstract] [Full Text] [Related]
26. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
[TBL] [Abstract][Full Text] [Related]
27. Examining the increased IgM production and ursodeoxycholic acid treatment in PBC.
Lazaridis KN; Larusso NF
Gastroenterology; 2005 Feb; 128(2):498-500. PubMed ID: 15685560
[No Abstract] [Full Text] [Related]
28. Ursodeoxycholic acid enhances fractional calcium absorption in primary biliary cirrhosis.
Verma A; Maxwell JD; Ang L; Davis T; Hodges S; Northfield TC; Zaidi M; Pazianas M
Osteoporos Int; 2002 Aug; 13(8):677-82. PubMed ID: 12181628
[TBL] [Abstract][Full Text] [Related]
29. UDCA prophylaxis for post-transplant PBC recurrence prevention: Time to change practice.
Dyson JK; Jones DEJ
J Hepatol; 2020 Sep; 73(3):499-501. PubMed ID: 32576471
[No Abstract] [Full Text] [Related]
30. Primary biliary cirrhosis and bile acids.
Corpechot C
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S13-20. PubMed ID: 23141888
[TBL] [Abstract][Full Text] [Related]
31. Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis.
Zhang H; Yang J; Zhu R; Zheng Y; Zhou Y; Dai W; Wang F; Chen K; Li J; Wang C; Li S; Liu T; Abudumijiti H; Zhou Z; Wang J; Lu W; Wang J; Xia Y; Zhou Y; Lu J; Guo C
Drug Des Devel Ther; 2015; 9():567-74. PubMed ID: 25632224
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.
Lee YM; Kaplan MM
Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960
[TBL] [Abstract][Full Text] [Related]
33. Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study.
Eriksson LS; Olsson R; Glauman H; Prytz H; Befrits R; Rydén BO; Einarsson K; Lindgren S; Wallerstedt S; Wedén M
Scand J Gastroenterol; 1997 Feb; 32(2):179-86. PubMed ID: 9051880
[TBL] [Abstract][Full Text] [Related]
34. Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy.
Vespasiani-Gentilucci U; Rosina F; Pace-Palitti V; Sacco R; Pellicelli A; Chessa L; De Vincentis A; Barlattani M; Barlattani A; Feletti V; Mussetto A; Zolfino T; Russello M; Cozzolongo R; Garrucciu G; Niro G; Bacca D; Bertino G; Claar E; Ascione A; D'Adamo G; Adinolfi LE; Scifo G; Izzi A;
Scand J Gastroenterol; 2019 Oct; 54(10):1274-1282. PubMed ID: 31564176
[No Abstract] [Full Text] [Related]
35. Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid.
Chen L; Borozan I; Milkiewicz P; Sun J; Meng X; Coltescu C; Edwards AM; Ostrowski MA; Guindi M; Heathcote EJ; McGilvray ID
Liver Int; 2008 Aug; 28(7):997-1010. PubMed ID: 18422935
[TBL] [Abstract][Full Text] [Related]
36. The use of ursodeoxycholic acid in patients with primary biliary cirrhosis: sense or nonsense.
Van Den Bogaert E; Francque S; Pelckmans P; Michielsen P
Acta Gastroenterol Belg; 2003; 66(4):283-7. PubMed ID: 14989050
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy of combined administration of ursodeoxycholic acid and hepthral in the treatment of primary biliary cirrhosis].
Avezov SA; Mansurov FKh
Klin Med (Mosk); 2004; 82(3):55-8. PubMed ID: 15114777
[TBL] [Abstract][Full Text] [Related]
38. [Ursodeoxycholic acid in the treatment of chronic cholestatic liver disease. Documented delay in disease progress inspires hope].
Olsson R
Lakartidningen; 2002 Mar; 99(12):1325-30. PubMed ID: 11998165
[TBL] [Abstract][Full Text] [Related]
39. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
[TBL] [Abstract][Full Text] [Related]
40. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
